DLK1 and neoplasm: The target pathway enrichment analysis revealed that DEMIRs encoded by Dlk1-Dio3 GIR might have a crucial role in driving hepatocarcinogenesis by regulating multiple tumor-associated metabolic pathways (Table 1).